title: Subgroup analyses in randomised controlled trials: cohort study on trial protocols and journal publications.
abstract: OBJECTIVE
  To investigate the planning of subgroup analyses in protocols of randomised controlled trials and the agreement with corresponding full journal publications.
  
  
  METHODS
  Cohort of protocols of randomised controlled trial and subsequent full journal publications.
  
  
  METHODS
  Six research ethics committees in Switzerland, Germany, and Canada.
  
  
  METHODS
  894 protocols of randomised controlled trial involving patients approved by participating research ethics committees between 2000 and 2003 and 515 subsequent full journal publications.
  
  
  RESULTS
  Of 894 protocols of randomised controlled trials, 252 (28.2%) included one or more planned subgroup analyses. Of those, 17 (6.7%) provided a clear hypothesis for at least one subgroup analysis, 10 (4.0%) anticipated the direction of a subgroup effect, and 87 (34.5%) planned a statistical test for interaction. Industry sponsored trials more often planned subgroup analyses compared with investigator sponsored trials (195/551 (35.4%) v 57/343 (16.6%), P<0.001). Of 515 identified journal publications, 246 (47.8%) reported at least one subgroup analysis. In 81 (32.9%) of the 246 publications reporting subgroup analyses, authors stated that subgroup analyses were prespecified, but this was not supported by 28 (34.6%) corresponding protocols. In 86 publications, authors claimed a subgroup effect, but only 36 (41.9%) corresponding protocols reported a planned subgroup analysis.
  
  
  CONCLUSIONS
  Subgroup analyses are insufficiently described in the protocols of randomised controlled trials submitted to research ethics committees, and investigators rarely specify the anticipated direction of subgroup effects. More than one third of statements in publications of randomised controlled trials about subgroup prespecification had no documentation in the corresponding protocols. Definitive judgments regarding credibility of claimed subgroup effects are not possible without access to protocols and analysis plans of randomised controlled trials.
authors.forename: Benjamin
authors.initials: B
authors.lastname: Kasenda
authors.forename: Stefan
authors.initials: S
authors.lastname: Schandelmaier
authors.forename: Xin
authors.initials: X
authors.lastname: Sun
authors.forename: Erik
authors.initials: E
authors.lastname: von Elm
authors.forename: John
authors.initials: J
authors.lastname: You
authors.forename: Anette
authors.initials: A
authors.lastname: Blümle
authors.forename: Yuki
authors.initials: Y
authors.lastname: Tomonaga
authors.forename: Ramon
authors.initials: R
authors.lastname: Saccilotto
authors.forename: Alain
authors.initials: A
authors.lastname: Amstutz
authors.forename: Theresa
authors.initials: T
authors.lastname: Bengough
authors.forename: Joerg J
authors.initials: JJ
authors.lastname: Meerpohl
authors.forename: Mihaela
authors.initials: M
authors.lastname: Stegert
authors.forename: Kelechi K
authors.initials: KK
authors.lastname: Olu
authors.forename: Kari A O
authors.initials: KA
authors.lastname: Tikkinen
authors.forename: Ignacio
authors.initials: I
authors.lastname: Neumann
authors.forename: Alonso
authors.initials: A
authors.lastname: Carrasco-Labra
authors.forename: Markus
authors.initials: M
authors.lastname: Faulhaber
authors.forename: Sohail M
authors.initials: SM
authors.lastname: Mulla
authors.forename: Dominik
authors.initials: D
authors.lastname: Mertz
authors.forename: Elie A
authors.initials: EA
authors.lastname: Akl
authors.forename: Dirk
authors.initials: D
authors.lastname: Bassler
authors.forename: Jason W
authors.initials: JW
authors.lastname: Busse
authors.forename: Ignacio
authors.initials: I
authors.lastname: Ferreira-González
authors.forename: Francois
authors.initials: F
authors.lastname: Lamontagne
authors.forename: Alain
authors.initials: A
authors.lastname: Nordmann
authors.forename: Viktoria
authors.initials: V
authors.lastname: Gloy
authors.forename: Heike
authors.initials: H
authors.lastname: Raatz
authors.forename: Lorenzo
authors.initials: L
authors.lastname: Moja
authors.forename: Rachel
authors.initials: R
authors.lastname: Rosenthal
authors.forename: Shanil
authors.initials: S
authors.lastname: Ebrahim
authors.forename: Per O
authors.initials: PO
authors.lastname: Vandvik
authors.forename: Bradley C
authors.initials: BC
authors.lastname: Johnston
authors.forename: Martin A
authors.initials: MA
authors.lastname: Walter
authors.forename: Bernard
authors.initials: B
authors.lastname: Burnand
authors.forename: Matthias
authors.initials: M
authors.lastname: Schwenkglenks
authors.forename: Lars G
authors.initials: LG
authors.lastname: Hemkens
authors.forename: Heiner C
authors.initials: HC
authors.lastname: Bucher
authors.forename: Gordon H
authors.initials: GH
authors.lastname: Guyatt
authors.forename: Matthias
authors.initials: M
authors.lastname: Briel
mesh_terms: D002170:Canada; D002985:Clinical Protocols; D015331:Cohort Studies; D003625:Data Collection / Q000379:methods; D005858:Germany; D006801:Humans; D011643:Publishing / Q000706:statistics & numerical data*; D016032:Randomized Controlled Trials as Topic / Q000379:methods*; D012107:Research Design; D013557:Switzerland